Truncating variants in the SHANK1 gene are associated with a spectrum of neurodevelopmental disorders

Halie May(Columbia University Irving Medical Center), Kwame Anyane‐Yeboa(Columbia University Irving Medical Center), Constance Smith‐Hicks(Kennedy Krieger Institute), Maria resa Te Carminho A. Rodrigues(University Hospital of Geneva), Charles Conlon(Kennedy Krieger Institute), David B. Goldstein(Electronic BioSciences (United States)), Michel Guipponi(University Hospital of Geneva), Samantha Toy(Washington University in St. Louis), Aida Telegrafi(GenVec), Joël Fluss(University Hospital of Geneva), Evan H. Baugh(Columbia University), Vimla S. Aggarwal(Columbia University Irving Medical Center), Katherine W. Roche(National Institute of Neurological Disorders and Stroke), Julie S. Cohen(Kennedy Krieger Institute), Júlia Baptista(University of Exeter), Michelle Primiano(NewYork–Presbyterian Hospital), Anna Chassevent(Kennedy Krieger Institute), Naomichi Matsumoto(Yokohama City University), Yuri Uchiyama(Yokohama City University), Armand Bottani(University Hospital of Geneva), Anya Revah‐Politi(A&G Pharmaceutical (United States)), Chong Ae Kim(AstraZeneca (United States)), Jae‐Hoon Jeong(Korea Institute of Radiological and Medical Sciences), Richard Person(GenVec), Marwan Shinawi(St. Louis Children's Hospital), Julia Rankin(Royal Devon & Exeter NHS Foundation Trust), Louise Bier(Columbia University Irving Medical Center)
Genetics in Medicine
June 10, 2021
Cited by 17


Related Papers